NLRP3 and metabolic dysfunction-associated steatotic liver disease: In different mouse models, Henao-Meja et al. [255] investigated the role of innate immunity inflammasomes NLRP6 and NLRP3 and the protein IL-18 on NAFLD/NASH progression, with respect to the gut microbiome.